SLC7A11 expression is lower in ARID1A-deficient compared with ARID1A-proficient cancer cells, contributing to a decrease in basal GSH levels and an increase in ROS in ARID1A-deficient cells (56). This evidence concerns the gene ARID1A and cancer.